Position in GH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$755,551
+$258,416 QoQ
Shares Held
5,036
-6.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#343
of 594 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $46,204,706 across 14 Diagnostics & Research names. GH ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
27,938 | $14,006,995 | |
| 2 | DHR |
Danaher Corp /De/
|
48,826 | $9,300,376 | |
| 3 | DGX |
Quest Diagnostics Inc
|
39,020 | $8,270,289 | |
| 4 | ILMN |
Illumina, Inc.
|
38,891 | $6,838,204 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,992 | $1,575,108 | |
| 6 | WAT |
Waters Corp /De/
|
3,673 | $1,377,521 | |
| 7 | A |
Agilent Technologies, Inc.
|
8,921 | $1,184,976 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
5,036 | $755,551 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $755,551 | 5,036 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $497,135 | 5,382 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $547,674 | 5,362 | Shares | Sole | 2026-02-02 | |
| 2025-03-31 | $442,273 | 10,382 | Shares | Sole | 2025-04-23 | |
| 2020-12-31 | $212,780 | 1,651 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||